carbapenems has been researched along with calcimycin in 1 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 11,946 | 40 | 444 |
| Protein | Taxonomy | carbapenems (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ainsa, JA; Briffotaux, J; Buchieri, MV; Cimino, M; Gicquel, B; Hao, P; Huang, W; Liu, L; Namouchi, A; Wang, X | 1 |
1 other study(ies) available for carbapenems and calcimycin
| Article | Year |
|---|---|
Ionophore A23187 shows anti-tuberculosis activity and synergy with tebipenem.
Topics: Antibiotics, Antitubercular; Bacterial Proteins; Calcimycin; Calcium Ionophores; Carbapenems; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Genotype; Humans; Macrophages; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis | 2017 |